Related Experiment Video
Updated: May 24, 2026

Utilizing Thermal Shift Assay to Probe Substrate Binding to Selenoprotein O
Published on: August 9, 2024
Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa)
A M Scarf1, C Luus, E Da Pozzo
1Discipline of Pharmacology, University of Sydney NSW 2006, Australia.
Abstract:
The translocator protein (TSPO) (18 kDa) is an emerging drug target for the treatment of numerous pathologies including cancer and neurodegenerative disease. However, our limited knowledge of TSPO binding site(s) has hindered the development of TSPO ligands with potential therapeutic effects. We have synthesized a series of pyrrolobenzoxazepines (1-10) to better characterize the interaction of ligands with the TSPO across species, and to determine their functional profiles. All ligands 1-10 displaced the binding of [3H]PK 11195 to the TSPO at nanomolar concentrations, with discrepancies in binding affinity between rat and human TSPO. Interestingly, non-linear regression analysis revealed that some ligands bound to the protein with a Hill slope not equal to 1.0, suggesting possible additional TSPO binding sites with allosteric effects. However, this trend was not conserved between rat and human. When tested for their effects on pregnenolone production in rat C6 glioma cells, nitric oxide release in murine microglia, and cell proliferation in human MCF-7 breast cancer cells, the pyrrolobenzoxazepines (40 μM) displayed functional effects which did not correlate to the binding trend observed in competition assays. We propose that consideration of species differences and binding site cooperativity, plus optimization of currently accepted functional assays, will aid in the development of drugs targeting TSPO that can be used as therapeutics for human disease.
Insights
Researchers developed new pyrrolobenzoxazepine compounds to study the translocator protein (TSPO), revealing species-specific binding and functional differences crucial for developing TSPO-targeted therapeutics.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- The translocator protein (TSPO) is a key drug target for cancer and neurodegenerative diseases.
- Limited understanding of TSPO binding sites impedes therapeutic ligand development.
- Species-specific TSPO characteristics complicate drug discovery.
Purpose of the Study:
- To synthesize and characterize pyrrolobenzoxazepine ligands for TSPO.
- To investigate species differences in TSPO ligand binding and function.
- To explore potential allosteric effects and cooperativity at TSPO binding sites.
Main Methods:
- Synthesis of pyrrolobenzoxazepine compounds (1-10).
- Competition binding assays using [3H]PK 11195 with rat and human TSPO.
- Non-linear regression analysis to determine binding kinetics (Hill slope).
- Functional assays: pregnenolone production, nitric oxide release, and cell proliferation.
Main Results:
- All synthesized ligands bound to TSPO with nanomolar affinity.
- Significant discrepancies in binding affinity were observed between rat and human TSPO.
- Some ligands exhibited Hill slopes not equal to 1.0, suggesting allosteric modulation, but this was not conserved across species.
- Functional effects in cellular assays did not correlate with binding affinities.
Conclusions:
- Species differences in TSPO binding are critical and must be considered.
- Potential allosteric effects and binding site cooperativity warrant further investigation.
- Optimization of functional assays and consideration of species variability are essential for developing effective TSPO-based therapeutics.
Related Concept Videos
Protein Translocation Machinery on the ER Membrane
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

